The business may not be as strong as its performance this year suggests.

Artificial intelligence (AI) isn't the only industry with explosive growth potential.

Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...

Immunology biotech Agomab Therapeutics is seeking to raise up to $212.5 million in its Nasdaq debut, joining a series of biotechs chipping away at 2025’s iced-over IPO market. | Immunology biotech ...

The biotech sector is one that’s become red-hot, at least in recent years. After around a decade of stagnation, investors ...

State officials on Monday have announced renovation plans at SUNY Upstate Medical Center’s CNY Biotech Accelerator as well as nearly $3 million in funding to help advance the ...

Cantai launched in 2023 with a $3 million seed round. The company has raised $6.55 million to date at an undisclosed valuation, according to PitchBook. It develops drug candidates with special ...

A research team led by the University of Oxford's Department of Engineering Science has shown it is possible to engineer a ...

Venture capitalists point to a surge in M&A and a glint of revival in the IPO arena as signs of better days ahead.

Hands-on biotech training delivers credentials, research projects, and real lab access for San Antonio students—fueling ...

The U.S. biotechnology market enters 2026 as the largest global biotech market, with an estimated size of $552.39 billion in 2023, and is projected to grow to $1.24 trillion by 2030.